Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

Share this content:
Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

Sponsors and Collaborators

Hellenic Oncology Research Group
University Hospital of Crete

Contacts
Dora Hatzidaki
+302810392570
dorachat@med.uoc.gr

Eva Maragkoudaki
+302810392857
dorachat@med.uoc.gr 

Principal Investigator
Nikos Androulakis, MD, University Hospital of Crete, Dept. of Medical Oncology

ClinicalTrials.gov Identifier
NCT00635726

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters